Thomas Fleischer et al.
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
Molecular Oncology 2024, vol. 18, issue 8
doi: 10.1002/1878-0261.13656